Catalyst calendar
Data as of 2026-08-19 16:00 UTC · tracked universe polled every 15 minutes
Three kinds of date: a PDUFA date (the deadline the FDA sets itself to decide on a drug application), an AdCom (an FDA advisory-committee meeting that reviews it in public), and a readout window (when a trial's results are expected). Dates marked confirmed by the company come from an 8-K or press-release quote; our estimate is a rule-derived window off the trial's registered primary-completion date (see methodology) — never shown the same way. Today: 200 estimated readout windows and 0 disclosed PDUFA/AdCom dates.
Next 7 days
| Date | Ticker | Phase | Event |
|---|---|---|---|
| 2027-04-27 in 36w | $ALNY | Phase 1 | A Study to Evaluate ALN-2232 in Participants With Obesity NCT07463846 |
| 2027-04-30 in 36w | $ARGX | Phase 2 | A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous… NCT04280718 |
| 2027-04-30 in 36w | $INCY | Phase 1 | Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis… NCT04279847 |
| 2027-04-30 in 36w | $INCY | Phase 3 | A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6… NCT06804811 |
| 2027-05-04 in 37w | $AMGN | Phase 3 | Study to Evaluate Efficacy and Safety of Romosozumab Compared With… NCT05972551 |
| 2027-05-10 in 38w | $REGN | Phase 1 | Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With… NCT03564340 |
| 2027-05-15 in 38w | $REGN | Phase 1 | A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic… NCT06836609 |
| 2027-05-20 in 39w | $BIIB | Phase 3 | A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017… NCT03958877 |
| 2027-05-26 in 40w | $BIIB | Phase 4 | A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in… NCT07223723 |
| 2027-05-28 in 40w | $ALNY | Phase 2 | A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2… NCT07465224 |
| 2027-05-31 in 41w | $SRPT | Phase 3 | A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of… NCT05881408 |
| 2027-05-31 in 41w | $VRTX | Phase 3 | Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With… NCT06628908 |
| 2027-05-31 in 41w | $BIIB | Phase 3 | A Study to Learn About the Effects of Felzartamab Infusions on Adults With… NCT06935357 |
| 2027-06-01 in 41w | $INCY | Phase 2 | A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With… NCT06388564 |
| 2027-06-06 in 42w | $VRTX | Phase 3 | Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With… NCT05329649 |
| 2027-06-09 in 42w | $VRTX | Phase 3 | Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants… NCT05477563 |
| 2027-06-21 in 44w | $ITCI | Phase 3 | Multicenter Study of Lumateperone for the Treatment of Irritability Associated… NCT06690398 |
| 2027-06-21 in 44w | $ITCI | Phase 3 | Multicenter Study of Lumateperone for the Treatment of Irritability Associated… NCT06706674 |
| 2027-06-23 in 44w | $BPMC | Phase 2 | (PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A… NCT03731260 |
| 2027-06-25 in 44w | $APLS | Phase 2 | A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to… NCT07215390 |
| 2027-06-25 in 44w | $BIIB | Phase 1 | A Study to Find Out How Nusinersen is Processed in the Body When Given Through… NCT06555419 |
| 2027-06-30 in 45w | $ALNY | Phase 2 | HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female… NCT07575308 |
| 2027-06-30 in 45w | $AMGN | Phase 3 | A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism… NCT03969329 |
| 2027-06-30 in 45w | $VRTX | Phase 3 | A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type… NCT04786262 |
| 2027-06-30 in 45w | $AMGN | Phase 3 | A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab… NCT05920356 |